Lasting Complete Clinical Response of a Recurring Cutaneous Squamous Cell Carcinoma With MEK Mutation and PIK3CA Amplification Achieved by Dual Trametinib and Metformin Therapy

JCO PRECISION ONCOLOGY

LIPPINCOTT WILLIAMS & WILKINS

1. Hungarian Innovation Agency [2019-1.1.1PIACI-KFI-2019-00367]